Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline
should not be considered exclusive of other methods of care reasonably directed at obtaining the
same results. e ultimate judgment concerning the propriety of any course of conduct must be
made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated
with the distributor of this clinical reference tool.
Abbreviations
ACIP, Advisory Committee on Immunization Practices; anti-HBs, antibodies to
hepatitis B surface antigen; CDC, Centers for Disease Control and Prevention; CGD,
chronic granulomatous disease; CSF, cerebrospinal fluid; DT, diphtheria-tetanus vaccine;
DTaP, diphtheria-tetanus-acellular pertussis vaccine; GVHD, gra-vs-host disease;
HepA, hepatitis A vaccine; HepB, hepatitis B vaccine; Hib, Haemophilus influenzae
type b conjugate vaccine; HIV, human immunodeficiency virus; HPV2, bivalent human
papillomavirus vaccine; HPV4, quadrivalent human papillomavirus vaccine; HSCT,
hematopoietic stem cell transplant; IIV, inactivated influenza vaccine; IPV, inactivated
poliovirus vaccine; LAIV, live attenuated influenza vaccine; MBL, mannan-binding
lectin; MCV4, quadrivalent meningococcal conjugate vaccine; MMR, measles, mumps,
and rubella vaccine; MMRV, quadrivalent MMR-varicella vaccine; MPSV4, quadrivalent
meningococcal polysaccharide vaccine; OPV, oral poliovirus vaccine; PCV, pneumococcal
conjugate vaccine; PCV7, 7-valent PCV; PCV13, 13-valent PCV; PPSV23, 23-valent
pneumococcal polysaccharide vaccine; SCID, severe combined immunodeficiency; SOT,
solid organ transplant; Td, tetanus-reduced diphtheria vaccine; Tdap, tetanus-reduced
diphtheria-reduced acellular pertussis vaccine; VAR, varicella vaccine; ZOS, zoster
vaccine.
Source
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A,
Dhanireddy S, Sung L, Keyserling H, Kang I. 2013 IDSA Clinical Practice Guideline for
Vaccination of the Immunocompromised Host. Clin Infect Dis. 2013. [Epub ahead of
print; http://cid.oxfordjournals.org/content/early/2013/11/26/cid.cit684]
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies: info@GuidelineCentral.com
Copyright © 2014 All rights reserved
IDSAVAC14033
